Shah Chetan has reported a transaction involving the forfeiture of 436 shares of common stock, which occurred on September 30, 2026. This transaction was necessitated by tax withholdings related to the conversion of restricted stock units into shares. Such updates are significant as they reflect ongoing adjustments in ownership and compliance with SEC regulations.
Shah Chetan is associated with Aethlon Medical Inc., a company in the surgical and medical instruments industry. The company is headquartered in San Diego, California, and is known for its innovative approaches in medical technology. The recent filing, dated October 15, 2026, is part of a series of Form 4 submissions that detail ownership changes and transactions by insiders.
According to the filing, the forfeited shares were part of a conversion of 1,091 vested and outstanding restricted stock units. These units were converted to cover tax withholdings based on the market price of Aethlon's common stock at the time of forfeiture. Following this transaction, Chetan retains ownership of 3,787 shares of the company.
This update may affect stakeholders and investors by providing transparency into the equity management practices of company executives. The surgical and medical instruments industry may see implications as executives navigate their equity stakes, which can influence investor confidence and market perceptions.
The filing does not indicate what happens next regarding further transactions or changes in ownership. However, it highlights the importance of compliance and the management of executive compensation in the medical technology sector.